Brand Name: Neurolep
Manufacturer : Square Pharmaceuticals Ltd.
COMPOSITION
Neurolep® Tablet: Each tablet contains Piracetam BP 800 mg.
Neurolep® Solution: Each 5 ml contains Piracetam BP 500 mg.
INDICATION
Cerebral vascular accidents and cerebral insufficiencies: Ischaemic or even haemorrhagic acute accidents, chronic manifestations of the above accidents or of cerebral atherosclerosis. Mental retardation in children: Ease of resuming individual contact, sociability and learning, improved intellectual performances and school results. Behaviour and psychotic problems in old age: Memory deficits, particularly with regard to fixation and evocation asthenia adaption disorders, disturbed psychomotor reactions.
DOSAGE & ADMINISTRATION
Adults: In cerebro-cortical insufficiency disorders, usual dose is 800 mg 3 times a day.
In myoclonic seizures, a dose of 7.2 gm daily, increasing by 4.8 gm per day every 3
to 4 days up to maximum of 20 gm daily, given in 2 or 3 divided doses.
Children: The daily dosage depends on the weight of the child, 50 mg/kg of body
weight in 3 divided doses.
Once the desired results has been obtained, reduce the initial dose by half.
SIDE EFFECTS
The side effects reported include nervousness, agitation, irritability, anxiety and sleep disturbances. The incidence of these during clinical trials was ( 5% ) and they were more often noted in the older patients taking > 2.4 gm daily. In
the majority of cases, a dose reduction sufficed to make these symptoms disappear. Some patients may complain of fatigue or drowsiness, gastrointestinal problems, e.g. nausea, vomiting, diarrhoea and stomachache have also been
reported but their incidence during clinical trials was <_ 2%. Other symptoms e.g. vertigo, headaches, trembling and sexual stimulation have occasionally been reported. Overdose: Piracetam appears to be devoid of toxicity even at very high doses and, therefore, the need for specific measures to be taken in case of an overdose is avoided. Drug
Interactions: In a single case, confusion, irritability and sleep disorders were reported in concomitant use with thyroid extract. At present, no interaction has been observed with the following anti-epileptic drugs, clonazepam, carbamazepine, phenyton, phenobarbitone and sodium valporate, based on a small number of studies.
Reviews
There are no reviews yet.